|
Editorials are a short article expressing an opinion or point of view. Often, but not always, written by a member of the publication staff.
Index:
2008
|
Yusuf S, Bosch J, Devereaux PJ, Collins R, Baigent C, Granger C, Califf R, Temple R. Sensisble guidelines for the conduct of large randomized trials. Clinical Trials 2008; 5: 38-39
|
|
Alonso-Coello P, Paniagua P, Mizera R, Devereaux PJ. Should physicians initiate B-blocker therapy in patients undergoing non-cardiac surgery? Pol Arch Med Wewn; 118: 616-618
|
2007
|
Devereaux PJ, Alonso-Coello P. The need to undertake and report rigorously randomized clnical trials. Rev Esp Anestesiol Reanim 2007; 54: 331-332
|
|
DeMets DL, Yusuf S. The Data and Safety Monitoring Committee: some final thoughts. Am Heart J 2001; 141: 548-9.
|
|
Yusuf S, Ã"unpuu S. Tackling the growing epidemic of cardiovascular disease in South Asia. J Am Coll Card 2001; 38(3): 688-9.
|
|
MacQueen G, Santa-Barbara J, Neufeld V, Yusuf S, Horton R. Health and peace: time for a new discipline. Lancet 2001; 358(9288): 1183-4.
|
|
Natarajan MK, Mehta S, Yusuf S. Management of myocardial infarction: looking beyond efficacy. JACC 2000; 35(2): 380-381.
|
|
Natarajan MK, Mehta S, Yusuf S. Management of myocardial infarction: looking beyond efficacy. JACC 2000; 35(2): 380-381.
|
|
Ã"unpuu S, Anand SS, Yusuf S. The impending global epidemic of cardiovascular diseases. Eur Heart J 2000; 21: 880-883.
|
|
Yusuf S. Clinical, public health, and research implications of the Heart Outcomes Prevention Evaluation (HOPE) Study. Eur Heart J 2000; 22: 103-104.
|
|
Natarajan MK, Mehta S, Yusuf S. Management of myocardial infarction: looking beyond efficacy. JACC 2000; 35(2): 380-381.
|
|
Natarajan MK, Mehta S, Yusuf S. Management of myocardial infarction: looking beyond efficacy. JACC 2000; 35(2): 380-381.
|
|
Ã"unpuu S, Anand SS, Yusuf S. The impending global epidemic of cardiovascular diseases. Eur Heart J 2000; 21: 880-883.
|
|
Yusuf S. Clinical, public health, and research implications of the Heart Outcomes Prevention Evaluation (HOPE) Study. Eur Heart J 2000; 22: 103-104.
|
|
Yusuf S. Strategies for patient recruitment into clinical trials. J Card Failure 1998; 4(3): 235-236.
|
|
Yusuf S, Anand S, MacQueen G. Can medicine prevent war?. BMJ 1998; 317(7174): 1669-1670.
|
|
Yusuf S. Strategies for patient recruitment into clinical trials. J Card Failure 1998; 4(3): 235-236.
|
|
Yusuf S, Anand S, MacQueen G. Can medicine prevent war?. BMJ 1998; 317(7174): 1669-1670.
|
|
Yusuf S. The ten most commonly asked questions about the calcium channel blocker controversy. Cardiology in Review 1997;5(4).
|
|
Yusuf S, Pogue J. Primary angioplasty compared with thrombolytic therapy for acute myocardial infarction. JAMA 1997; 278(23):2110-2111.
|
|
Yusuf S. Digoxin in heart failure: results of the recent digoxin investigation group trial in the context of other treatments for heart failure. Eur Heart J 1997;18: 1685-1688.
|
|
Yusuf S. The ten most commonly asked questions about the calcium channel blocker controversy. Cardiology in Review 1997;5(4).
|
|
Yusuf S, Pogue J. Primary angioplasty compared with thrombolytic therapy for acute myocardial infarction. JAMA 1997; 278(23):2110-2111.
|
|
Rihal CS, Yusuf S. Chronic coronary artery disease: drugs, angioplasty, or surgery? Tailor the treatment to the patient. BMJ 1996; 312 (7026): 265-266.
|
|
Yusuf S, Anand S. Cost of prevention: the case of lipid lowering. Circ 1996; 93(10): 1774-1776.
|
|
Yusuf S. Verapamil following uncomplicated myocardial infarction: promising, but not proven. Am J Card 1996; 77(5): 421-422.
|
|
Yusuf S. The ten most commonly asked questions about the calcium channel blocker controversy. Cardiology in Review 1997;5(4).
|
|
Yusuf S, Tsuyuki R. Using exercise endpoints in heart failure trials: design considerations. Eur Heart J 1996; 17(1): 4-6.
|
|
Yusuf S. Flather M. Magnesium in acute myocardial infarction: ISIS 4 provides no grounds for its routine use. BMJ 1995; 310(6982):751-752.
|
|
Yusuf S. Calcium antagonists in coronary artery disease and hypertension: time for reevaluation? Circ 1995; 92(5): 1079-1082.
|
| 
